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Cardiovascular sensitivity to catecholamines was assess4 
in 15 patients with hypothyroidism ( ean [f SEMI thyrox- 
ine [Td] index 2.7 i 0.5 pg/loO ml, thyroid stimulating 
hormone [TSH] 136.9 + .3 /.&J/ml), aged 45 f 
and ia 8 healthy control subjects. The study was repeated in 
10 patients with hypothyroidism 4.0 f 0.5 months after 
thyroid replacement therapy (T4 index 2.1 #q/loo 
mi, TSH 3.5 f 1.3 @J/ml). In addition, average and 
maximal heart rates were measured using 24 h ambulatory 
electrocardiographic (KG) monitoring, and plasma levels 
of ephrephrine and norepinephrine w re determined before 
and after thyroid replacement. 
Heart rate increased less after bolus injection of 0.8,1.6 
and 3.2 jqg of isoprotereool in the hypothyroid (10 f 2,15 
P 2 and 21 i 4 beats/n@ respectively) than in tne 
euthyroid (16 f 3,22 i 3 and 30 I 4 beats/min, respec- 
Patients with hypothyroidism often present with bradycar- 
dia, ptosis of the eyelids and other signs of low sympathetic 
activity (1). However, their plasma norepinephrine and 
epinephrine l vels are high (2,3), suggesting decreased cat- 
echolamine sensitivity. The numerous tudies (4-13) of 
beta-adrenergic responsiveness in various animal models of 
hypothyroidism have had conflicting results. Similarly, 
whether decreased sensitivity to beta-adrenergic st mulation 
is present in patients with hypothyroidism is still controver- 
sial (14-17). Therefore, this study assessed the heart rate 
response to beta-adrenergic stimulation of patients with 
hypothyroidism before and after thyroid replacement ther- 
apy. 
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tively) state (p C 0.05). 
ear&c cbroaotro 
muximal daily heart rates seen in 
roidism, which occurs despite leva 
rine levels. 
Study patients. Fifteen patients (4 men and ii women), 
aged 27 to 76 years (mean f SEM 45 * 4), with newly 
diagnosed hypothyroidis.n were enrolled in this study from 
August 1987 to June 1988. No patient had cardiac disease or 
was receiving drugs that might interact with cardiac or 
autonomic nervous ystem function. All medications, except 
thyroxine, remained unchanged throughout the protocol. All 
patients gave written informed consent o this medical 
center’s Httman Subjects Committee-approved protocol. 
Ten of the IS patients underwent both a baseline study in 
the hypothyroid state and a repeat study during thyroid 
replacement therapy with thyroxine 4+ 0.5 months after the 
baseline study. Five of the patients completed the baseline 
study, but refused to undergo a repeat study while in a 
euthyroid state. 
Eight healthy control subjects (three men and five 
women) with a mean age of 42 + 4 years and normal thyroid 
fu ts completed the same p 
All patients were admi 
search Center at 9:CWI AM in the morning and had an 
intravenous line inserted. Blood was drawn for thyroid 
function tests. Patients then rested supine for at least 2 h 
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s were ana- 
heart rate was automat~ca~~~ combated by using a 16 beat 
sliding average after checking for motion artifacts. 
ment well. Their mean weight of 83.7 t 7 kg at baseline 
The isoproterenol infitsiun test gave reproducible heart 
rates, with a variability between injections of 4 2 4 beats/ 
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Figure 1. Plasma levels of norepinephrine m asured before (Hype) 
and after (Euth) thyroid replacement i  IO patients with hypothy 
roidism. 
min (mean + SD). Patients reported minor side effects of 
palpitation (eight patients), deep sighing (eight patients), 
anxiety (five patients) and flushing (three patients). After 
injection of saline solution, the average increase inheart rate 
was 3 + 1 beat&n (mean k SEM). Injections of 0. I to 0.4 
pg of isoproterenol resulted in only a minimal increase in 
heart rate in patients with hypothyroidism and control sub- 
jects (Fig. 2). After injection of 0.8, 1.6 and 3.2 H of 
isoproterenol, the increase in heart rate was significantly 
blunted in patients who had not yet received replacement 
40 i 
156 6.4 mcg 
30 : 
20 10 7 
01 
HYPO Euth 
HYPO Euth 
Table 2. Decreases inDiastolic Blood Pressure (mm Hg) After 
Injection of Isoproterenol 
lsoproterenol 
All patients with hypothyroidism tn = 10) 
PaGents in a hypolhyroid state (n = 7)* 
Patients in a euthyroid state (n = 7)* 
Control subjects (n = 8) 
0.8 pg 1.6 j.~6 3.2 erg 
4 2 2 13 f 2 16 i 4 
422 14 f 3 20 + 5 
IO + 2 20 f 5 31 r1 
12 + 2 22 2 4 22 + 6 
*Seven paGents studied before and abler replacement therapy. 
therapy. Seven patients with hypothyroidism required 4.4 ccg 
and three required 12.8 clg of isoproterenol before thyroid 
replacement. After thyroid replacement, only two patients 
required 6.4 cog and none required 12.8 M. The increase in 
heart rate was also significantly ower w”len all 15 patients 
with hypothyroidism were compared with the control sub- 
jects (Fig. 2). 
There was no significant correlation between the degree 
of hypothyroidism, assessed by T4 index and TSH levels, 
and the heart rate increase after injections of isoproterenol. 
Baseline blood pressure measurements were similar in 
patients in the hypothyroid and the euthyroid state (125 rt 
8/83 k 5 versus 127 2 7183 -I 6 mm Hg). Decreases in 
diastolic blood pressure during isoproterenol infusion tended 
to be smaller in patients with hypothyroidism than in pa- 
tients in the euthyroid state or in control subjects, although 
these differences did not reach statistical significance (Table 
2). However, the changes in blood pressure during the 
40 
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T IS0 1.6 mcg IS0 3 2 mcg r P’O.05 -I T I- P’O.05 -l 
All Hypo Controls 
IS0 6.4 mcg 
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: 
I_- 
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Figure 2. lsoproterenol (ISO) sensitivity test re- 
sults. A, Ten patients studied both before (Hype) 
and after (Euth) thyroid replacement. B, Fifteen 
patients with hypothyroidism (All Hype) and eight 
control subjects (Controls). 
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asal, average and maxilrd hean rates recorded du61g 24 
rine levels and increased cardiac bronotro~ic res~o~s~ve- 
roidism. Further- 
monitoring. Thyroid replacement 
increased heart rate response to adrenergic stimuiat~o~. 
e contribution of these two -mechanisms 
Its. Admi~jstrat~on 
occurs in euthyroid rats (8,12) and a smaller ~hronotro~~~ 
response to isoproterenol (9.13). These differences may be 
due to a decrease inthe number of beta-adrenergic re eptors 
(5). Studies performed in paiients with hypothyroidism also 
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